CBD based products have the potential to see significant growth in the Israeli market over the forecast period, provided that they are marketed correctly, as consumers are seeking more natural products to combat pain. Much will depend on how well received Cannasen is in Israel, and it will be interesting to see if this product becomes very popular or if it suffers from a lack of consumer information or negative beliefs about CBD consumption.
Amongst analgesics brands, well-established consumer favourites, Acamol, Decamol and Optalgin are likely to lead the market over the foreseeable future as people know and trust these brands. In addition, these brands are widely available both online and in pharmacies and have a good reputation in the country, which will continue to stimulate sales.
With the Israel-Hamas war ongoing, it is likely that an increasing number of adults and children will seek out products from the analgesics (systemic) and topical analgesics/anaesthetic categories to grapple with tension headaches and other types of tension related pain in the early part of the forecast period. In addition, the economic downturn seen in the early part of 2024 is likely to mean that people will continue to use private label products, as well as turning to larger packs that may be discounted in order to save money, which will constrain value growth in the analgesics category.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Analgesics industry in Israel with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Israel, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See All of Our DefinitionsThis report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!